Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Stratification and Coronary Optical Coherence Tomography Findings in Asymptomatic Patients With Type 1 Diabetes Mellitus.

Physiological research·2025
Same author

Structure, network density and domain architecture of transition-metal (Cu<sup>2+</sup>, Fe<sup>3+</sup>) cross-linked alginates as seen by paramagnetic solid-state nmr spectroscopy.

Carbohydrate polymers·2025
Same author

Soluble endoglin reflects endothelial dysfunction in myocardial infarction patients: a retrospective observational study.

International journal of medical sciences·2025
Same author

The Impact of COVID-19 Third Dose Vaccination on the Magnitude of Antigen Specific T Cells in Kidney Transplant Patients.

Physiological research·2024
Same author

Insights into IL-1 family cytokines in kidney allograft transplantation: IL-18BP and free IL-18 as emerging biomarkers.

Cytokine·2024
Same author

Circulating Cell-Free DNA Extraction from Liquid Biopsy for Cancer Research.

Folia biologica·2023

Related Experiment Video

Updated: Jun 21, 2026

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

Fetuin-A early after renal transplantation.

M Urbanová1, M Kalousová, T Zima

  • 1Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Kidney & Blood Pressure Research
|July 23, 2009
PubMed
Summary

Serum fetuin-A levels did not increase in the first 3 months post-kidney transplant. A notable decrease in fetuin-A was observed at 2 weeks, followed by a recovery to pre-transplant levels.

More Related Videos

Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

Related Experiment Videos

Last Updated: Jun 21, 2026

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

Area of Science:

  • Nephrology
  • Immunology
  • Cardiovascular Science

Background:

  • Fetuin-A inhibits ectopic calcification and is an acute phase reactant.
  • Fetuin-A deficiency in end-stage renal disease is linked to cardiovascular issues.
  • Monitoring fetuin-A post-renal transplant is crucial for understanding cardiovascular risk.

Purpose of the Study:

  • To track serum fetuin-A levels in the early post-renal transplant period.
  • To investigate the association of fetuin-A with clinical and laboratory parameters after transplantation.

Main Methods:

  • Prospective study of 30 deceased donor kidney recipients.
  • Patients received calcineurin inhibitor-based immunosuppression.
  • Fetuin-A levels monitored for 3 months post-transplant.

Main Results:

  • Fetuin-A levels correlated with creatinine clearance and estimated GFR.
  • No significant increase in fetuin-A observed over 3 months.
  • A significant decrease in fetuin-A at 2 weeks, followed by an increase to pre-transplant levels by 3 months.

Conclusions:

  • Serum fetuin-A levels do not increase in the first 3 months after renal transplantation.
  • A transient decrease in fetuin-A occurs at 2 weeks post-transplant.
  • Fetuin-A levels normalize by 3 months post-transplant.